Silicon nanoparticles for oral administration of molecular hydrogen

Hennie Marie Johnsen, Jo Klaveness, Marianne Hiorth, Werner Filtvedt

Read more:

DOI: 10.1016/j.ijpharm.2022.122371 DOI is the universal ID for this study.

This link will take you to the full study.


Medical use of hydrogen gas (H2) has been given increasing attention over the past 15 years with numerous clinical trials for a variety of indications. The biological activity of H2 includes antioxidant properties and thereby the ability to neutralize damaging reactive oxygen species (ROS). Administration of hydrogen as a medical gas is limited by the poor water solubility and by the flammability of H2 in air. Therefore, nanocarriers have been investigated for safer and more efficient administration of hydrogen. Silicon particles are suggested for oral administration with the ability to undergo a redox reaction with water to produce H2in vivo. The purpose of this work was to investigate the hydrogen generating abilities of silicon particles synthesized by centrifugal chemical vapor deposition (cCVD). High hydrogen generation rates up to 1310 ml/g at physiological pH 7.4 (82% yield) were observed. An in vitro model of oral administration showed that pretreatment in artificial gastric juice did not affect hydrogen generation. Thus, the cCVD silicon particles seem to be suitable for in vivo hydrogen generation. A surface carbon coating or addition of surfactants or albumin reduced hydrogen generation. The addition of egg white reduced hydrogen generation but did not block it.

Publish Year 2022
Country Norway
Rank Positive
Journal International Journal of Pharmaceutics
Primary Topic Whole Body
Secondary TopicHydrogen Biology
Model Molecular Assay
Tertiary TopicNovel Therapy
Vehicle Gas
pH N/A
Application In Vivo Biotic Production